MAZE – maze therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Maze Therapeutics (NASDAQ:MAZE) was given a new $55.00 price target on by analysts at Wells Fargo & Company. They now have an "overweight" rating on the stock.
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Maze Therapeutics, Inc. (MAZE) Presents at Jefferies London Healthcare Conference 2025 Prepared Remarks Transcript [Seeking Alpha]
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Raymond James Financial, Inc. to a "strong-buy" rating.
Maze Therapeutics (NASDAQ:MAZE) was downgraded by analysts at Wall Stree
Form 144 Maze Therapeutics, Inc. Filed by: Kathiresan Sekar
Form 4 Maze Therapeutics, Inc. For: Nov 19 Filed by: HOMCY CHARLES J
Form 144 Maze Therapeutics, Inc. Filed by: Kathiresan Sekar
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: Foresite Capital Fund IV, L.P.
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.